The idea that a core metabolic cofactor—one derived from dietary riboflavin and present in virtually every human cell—could simultaneously regulate two of the immune system's most critical threat-detection proteins reframes how metabolism and inflammation are fundamentally intertwined. This finding carries implications for autoimmune disease, antiviral defense, and the chronic low-grade inflammation associated with aging.
Published in Immunity, the research identifies flavin adenine dinucleotide (FAD) as a direct suppressor of both cGAS and RIG-I, the two principal cytosolic sensors that detect misplaced or foreign nucleic acids and trigger type-I interferon signaling. FAD was shown to physically occupy the catalytic pockets of both proteins, dampening their activation. When FAD synthase (FLAD1)—the enzyme responsible for FAD production—was genetically ablated, cells exhibited heightened autoinflammation and accelerated cellular senescence. Conversely, during viral infection, FLAD1 activity naturally declines, reducing intracellular FAD concentrations and effectively releasing the inhibitory brake on cGAS and RIG-I, allowing robust interferon-I responses. In mouse models, FLAD1 depletion enhanced antiviral immunity and improved survival outcomes.
This discovery positions FAD as a metabolic checkpoint at the interface of energy metabolism and immune surveillance—an entirely novel function for a molecule previously understood almost exclusively as a redox cofactor in mitochondrial respiration and fatty acid oxidation. The dual-sensor targeting is particularly noteworthy: most known immune modulators affect either the DNA-sensing (cGAS-STING) or RNA-sensing (RIG-I-MAVS) axis, not both simultaneously. From a longevity perspective, the FLAD1-ablation link to cellular senescence suggests that FAD homeostasis may be relevant to inflammaging pathways. Key limitations include reliance on mouse infection models and genetic knockout systems rather than pharmacological FAD manipulation in humans. Whether dietary riboflavin status meaningfully shifts intracellular FAD to immunologically relevant levels remains an open and important question.